Bausch & Lomb (BLCO) Non-Current Deferred Tax Liability (2021 - 2026)
Bausch & Lomb (BLCO) posted Non-Current Deferred Tax Liability of $19.0 million for Q1 2026, little changed on a QoQ basis from $19.0 million in Q4 2025, and up 46.15% year-over-year from $13.0 million in Q1 2025.
Bausch & Lomb (BLCO) Non-Current Deferred Tax Liability (2021 - 2026) Analysis & Trends
Bausch & Lomb's Non-Current Deferred Tax Liability history runs 6 years deep, the most recent figure standing at $19.0 million for Q1 2026.
- Quarterly Non-Current Deferred Tax Liability rose 46.15% year-over-year to $19.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $19.0 million (up 46.15% YoY) and the FY2025 annual result came in at $19.0 million, up 46.15% from the prior year.
- Non-Current Deferred Tax Liability was $19.0 million for Q1 2026 at Bausch & Lomb, roughly flat from $19.0 million in the prior quarter.
- Across five years, Non-Current Deferred Tax Liability topped out at $117.0 million in Q4 2022 and bottomed at $10.0 million in Q2 2022.
- A 5-year average of $25.0 million and a median of $14.0 million in 2023 frame the typical range for Non-Current Deferred Tax Liability.
- Annual changes were most pronounced in 2022 — Non-Current Deferred Tax Liability jumped 387.5% — and 2023, when it slumped 88.03%.
- Bausch & Lomb's Non-Current Deferred Tax Liability stood at $117.0 million in 2022, then slumped by 88.03% to $14.0 million in 2023, then slipped by 7.14% to $13.0 million in 2024, then soared by 46.15% to $19.0 million in 2025, then changed by 0.0% to $19.0 million in 2026.
- Business Quant data shows BLCO's Non-Current Deferred Tax Liability at $19.0 million in Q1 2026, $19.0 million in Q4 2025, and $14.0 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alcon | 32,734,969.19 Bn | 32,734,967.53 Bn | 1.53 Bn |
| 2 | Intuitive Surgical | 117.50 Bn | 112.41 Bn | 1.96 Bn |
| 3 | Becton Dickinson | 42.93 Bn | 42.11 Bn | 2.15 Bn |
| 4 | Medline | 30.82 Bn | 36.66 Bn | 1.84 Bn |
| 5 | Resmed | 27.90 Bn | 26.23 Bn | 890.98 Mn |
| 6 | West Pharmaceutical Services | 26.76 Bn | 26.23 Bn | 329.20 Mn |
| 7 | Cooper Companies | 15.30 Bn | 15.16 Bn | 735.40 Mn |
| 8 | Solventum | 13.46 Bn | 12.90 Bn | 1.10 Bn |
| 9 | Align Technology | 12.02 Bn | 10.96 Bn | 736.59 Mn |
| 10 | Bausch & Lomb | 5.68 Bn | 5.47 Bn | 973.00 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 19.00 Mn |
| Mar 31, 2026 | 19.00 Mn |
| Dec 31, 2025 | 19.00 Mn |
| Dec 31, 2025 | 19.00 Mn |
| Sep 30, 2025 | 14.00 Mn |
| Sep 30, 2025 | 14.00 Mn |
| Jun 30, 2025 | 14.00 Mn |
| Jun 30, 2025 | 14.00 Mn |
| Mar 31, 2025 | 13.00 Mn |
| Mar 31, 2025 | 13.00 Mn |
| Dec 31, 2024 | 13.00 Mn |
| Dec 31, 2024 | 13.00 Mn |
| Sep 30, 2024 | 12.00 Mn |
| Sep 30, 2024 | 12.00 Mn |
| Jun 30, 2024 | 14.00 Mn |
| Jun 30, 2024 | 14.00 Mn |
| Mar 31, 2024 | 14.00 Mn |
| Mar 31, 2024 | 14.00 Mn |
| Dec 31, 2023 | 14.00 Mn |
| Dec 31, 2023 | 14.00 Mn |